While declining to comment on the specific growth strategy, a Novo Holdings spokesperson confirmed a statement provided by its senior partner to Reuters last month.
The Spanish contract manufacturer, which will report its full-year results on Feb. 25, warned that analysts’ consensus 2024 EBITDA estimates are 10% to 15% too high.
